peace, maybe revenue might fall in line with your thoughts, but:
"Clinical Trials -
Double cost estimates & extend time frames by 12 months"
I'll put money on that not happening
ANP has always delivered under budget and on time or before in the past, and I expect that to remain the case
However, as you said, yes it's all speculation, as is the broad generalisation from a biotech analyst
